GSK682753A
≥99%
- Product Code: 62693
CAS:
1334294-76-6
| Molecular Weight: | 479.78 g./mol | Molecular Formula: | C₂₃H₂₁Cl₃N₂O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
GSK682753A is primarily utilized in the field of medical research, particularly in the study of neurological disorders. It serves as a potent and selective inhibitor of certain enzymes or receptors involved in brain function, making it a valuable tool for investigating pathways related to neurodegenerative diseases. Researchers employ this compound to explore potential therapeutic strategies for conditions such as Alzheimer's disease, Parkinson's disease, and other cognitive impairments. Its application extends to preclinical studies, where it helps in understanding the molecular mechanisms underlying these disorders and in evaluating the efficacy of novel treatments. Additionally, GSK682753A may be used in the development of diagnostic tools or biomarkers for early detection of neurological conditions.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | €392.49 |
+
-
|
| 0.010 | 10-20 days | €663.16 |
+
-
|
GSK682753A
GSK682753A is primarily utilized in the field of medical research, particularly in the study of neurological disorders. It serves as a potent and selective inhibitor of certain enzymes or receptors involved in brain function, making it a valuable tool for investigating pathways related to neurodegenerative diseases. Researchers employ this compound to explore potential therapeutic strategies for conditions such as Alzheimer's disease, Parkinson's disease, and other cognitive impairments. Its application extends to preclinical studies, where it helps in understanding the molecular mechanisms underlying these disorders and in evaluating the efficacy of novel treatments. Additionally, GSK682753A may be used in the development of diagnostic tools or biomarkers for early detection of neurological conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :